Euro-Sante :: Euro-Health

Archives for English

The ERRIN innovation event, The Hospital of the Future, 2 March 2010, explored the future of the hospital as a recipient of financially and environmentally sustainable investment. The key outcome for me, as one of the moderators of the event, was the emerging view of the hospital as a major innovator within their local/regional economies.… » read more

Posted by EuroSante

I had the distinct honour of speaking at and participating in a panel discussion at the European Foundation for Management Development conference at Advancia, in Paris recently. An informed group assembled to hear from entrepreneurs and academics. I was impressed with the work of Advancia and the support it gets from the Paris Chamber of… » read more

Posted by EuroSante

Writing about health issues also means thinking about how people learn — we all want our health professionals to be highly trained and educated. We are also generally mindful that talent should prevail over privilege. Such appears to be an issue for President Nicholas Sarkozy of France and the elitist Grandes Ecoles that enable the… » read more

Posted by EuroSante

We are all innovators now. Gone, surely, must be the days of free-riders, of subsidised mediocrity and creative malaise. A new world beckons. But doubts remain. I had the privilege of moderating an excellent post-Lisbon event on innovation for ERRIN, the European Regions Research and Innovation Network. What was so exciting was to hear from… » read more

Posted by EuroSante

It would be a serious mistake not have an EU-wide regulatory framework for internet pharmacies. Not achieving one would be just more evidence of the politics that infects all discussions of cross-border healthcare to the detriment of the patient and health consumer. Illegal drugs, fake drugs, reimported drugs, counterfeit drugs, substandard drugs, legitimate drugs —… » read more

Posted by EuroSante

Recent research suggests that the European pharmaceutical industry is more productive than the US one. Euractive reports on this here: article-184974. A few things to consider. Light’s work is a reanalysis of existing data. His conclusions are based on using the head-office of the company discovering the drug as determining the country of origin. He… » read more

Posted by EuroSante

Annalee Saxenian, an astute observer and analyst of the regional advantage of Silicon Valley, observes in her book, The New Argonauts, that the Valley has gained as its home-grown entrepreneurs have built overseas businesses in China, India and elsewhere. She notes: “By promoting the development of local capabilities in Tel Aviv, Hsinchu, Shanghai, Bangalore, and… » read more

Posted by EuroSante

NICE is the health technology assessment [HTA] agency in England, the one upon which others in many countries are modelled. More generally, HTA is increasingly being used by governments for more than simple economic evaluation of medicines and devices, but is being used as a form of rationing of access to technologies (medicines or devices… » read more

Posted by EuroSante